ELAN logo

ELAN

Profile

Full Name

Elanco Animal Health Incorporated

Ticker Symbol

ELAN

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

September 20, 2018

Indexes

Not included

Website

http://www.elanco.com

Employees

9000

Key Details

Price

$8.10(-1.70%)

Market cap

$4.02B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.44B(+0.50% YoY)

Annual EPS

$0.68(+127.20% YoY)

PE ratio

12.09

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$8.10
ELAN price is $8.10

30-Day Relative Volume

1.27
ELAN 30-day relative volume is 1.27

Price Performance

Price Most recent change

-1.7%
ELAN price was down -1.7% on Apr 16, 2025

Price YTD change

-33.11%
ELAN price is down -33.11% since January 1st

Price 1-year change

-40.62%
ELAN price is down -40.62% year-on-year

Price 3-year change

-69.14%
ELAN price is down -69.14% over the past 3 years

Price Range

Price All-time high

$37.61
ELAN price is currently -78.46% below its historical high of $37.61

Price 3-year low

$7.88
ELAN price is currently +2.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.02B
ELAN market capitalization is $4.02 billion

Market cap 3-year change

-67.69%
ELAN market capitalization is down -67.69% over the past 3 years

Market cap All-time high

$17.37B
ELAN market capitalization is currently -76.85% below its historical high of $17.37 billion

Market cap sector rank

88.4%
ELAN market capitalization is higher than 88.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.48%
ELAN shares outstanding is up +0.48% year-on-year

Shares Outstanding 3-Year Change

+4.72%
ELAN shares outstanding is up +4.72% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.18
ELAN beta is 1.18

200-day SMA

$12.58
ELAN price is currently -35.64% below its 200-day simple moving average

50-day SMA

$10.50
ELAN price is currently -22.89% below its 50-day simple moving average

RSI

31.83
ELAN 14-day relative strength index is 31.83

Volume

1.27
ELAN 30-day relative volume is 1.27

ATR

$0.62
ELAN average true range is $0.62

10-day Historical Volatility

99.29%
ELAN 10-day historical volatility is 99.29%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.44B
ELAN annual revenue is $4.44 billion

Revenue Analysts estimate

$4.49B
ELAN annual revenue is currently -1.07% lower than the consensus analysts' forecast

Revenue 1-year change

+0.5%
ELAN annual revenue is up +0.5% year-on-year

Revenue Sector rank

91.51%
ELAN annual revenue is higher than 91.51% of companies in Healthcare sector

EPS

EPS

$0.68
ELAN annual earnings per share is $0.68

EPS Analysts estimate

$0.84
ELAN annual earnings per share is currently -18.78% lower than the consensus analysts' forecast

EPS 1-year change

+127.2%
ELAN annual earnings per share is up +127.2% year-on-year

EPS Sector rank

87.9%
ELAN annual earnings per share is higher than 87.9% of companies in Healthcare sector

Profit

Gross profit

$2.44B
ELAN annual gross profit is $2.44 billion

Gross margin

54.88%
ELAN annual gross profit margin is 54.88%

Operating profit

$251.00M
ELAN annual operating income is $251.00 million

Operating margin

5.65%
ELAN annual operating profit margin is 5.65%

Net income

$338.00M
ELAN annual net profit is $338.00 million

Net margin

7.61%
ELAN annual net profit margin is 7.61%

Expenses

Total expenses

$4.19B
ELAN annual total expenses is $4.19 billion

Operating expenses

$2.19B
ELAN annual total operating expenses is $2.19 billion

Cost of goods sold

$2.00B
ELAN annual cost of goods sold is $2.00 billion

Selling, general & administrative expenses

$1.31B
ELAN annual SGA is $1.31 billion

Depreciation and amortization

$662.00M
ELAN annual depreciation & amortization is $662.00 million

Interest expense

$235.00M
ELAN annual interest expense is $235.00 million

Income tax

$150.00M
ELAN annual income tax is $150.00 million

EBIT & EBITDA

EBIT

$723.00M
ELAN annual earnings before interest & taxes is $723.00 million

EBITDA

$1.39B
ELAN annual EBITDA is $1.39 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.61B
ELAN annual total assets is $12.61 billion

Non current assets

$9.40B
ELAN annual long term assets is $9.40 billion

Current assets

$3.21B
ELAN annual total current assets is $3.21 billion

Cash and cash equivalents

$468.00M
ELAN annual cash & cash equivalents is $468.00 million

Accounts receivable

$805.00M
ELAN annual accounts receivable is $805.00 million

Inventory

$1.57B
ELAN annual inventory is $1.57 billion

Liabilities

Total liabilities

$6.52B
ELAN annual total liabilities is $6.52 billion

Long term liabilities

$5.20B
ELAN annual total long term liabilities is $5.20 billion

Current liabilities

$1.31B
ELAN annual total current liabilities is $1.31 billion

Accounts payable

$296.00M
ELAN annual accounts payable is $296.00 million

Debt

Total debt

$4.32B
ELAN annual total debt is $4.32 billion

Total debt 1-year change

-25.16%
ELAN annual total debt is down -25.16% year-on-year

Long term debt

$4.28B
ELAN annual long term debt is $4.28 billion

Short term debt

$44.00M
ELAN annual short term debt is $44.00 million

Equity & Capital

Shareholders equity

$6.10B
ELAN annual stockholders equity is $6.10 billion

Book value

$6.10B
ELAN annual book value is $6.10 billion

Retained earnings

-$1.95B
ELAN annual retained earnings is -$1.95 billion

Working capital

$1.90B
ELAN annual working capital is $1.90 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$541.00M
ELAN annual cash flow from operations is $541.00 million

Cash from operations 1-year change

+99.63%
ELAN annual cash flow from operations is up +99.63% year-on-year

Cash from investing

$1.16B
ELAN annual cash flow from investing activities is $1.16 billion

Cash from investing 1-year change

+785.21%
ELAN annual cash flow from investing activities is up +785.21% year-on-year

Cash from financing

-$1.49B
ELAN annual cash flow from financing activities is -$1.49 billion

Cash from financing 1-year change

-1697.59%
ELAN annual cash flow from financing activities is down -1697.59% year-on-year

CAPEX

CAPEX

$161.00M
ELAN annual capital expenditures is $161.00 million

CAPEX 1-year change

+4.55%
ELAN annual capital expenditures is up +4.55% year-on-year

Free Cash Flow

Free cash flow

$380.00M
ELAN annual free cash flow is $380.00 million

Free cash flow 1-year change

+224.79%
ELAN annual free cash flow is up +224.79% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.88%
ELAN annual gross profit margin is 54.88%

Operating margin

5.65%
ELAN annual operating profit margin is 5.65%

Net margin

7.61%
ELAN annual net profit margin is 7.61%

ROA & ROE

ROA

2.51%
ELAN annual return on assets is 2.51%

ROE

5.49%
ELAN annual return on equity is 5.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

12.09
ELAN price to earnings ratio is 12.09

PE ratio Sector rank

21.08%
ELAN price to earnings ratio is higher than 21.08% of companies in Healthcare sector

PB Ratio

PB ratio

0.66
ELAN price to book ratio is 0.66

PB ratio Sector rank

35.47%
ELAN price to book ratio is higher than 35.47% of companies in Healthcare sector

PS Ratio

PS ratio

0.91
ELAN price to sales ratio is 0.91

PS ratio Sector rank

26.28%
ELAN price to sales ratio is higher than 26.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$7.87B
ELAN enterprise value is $7.87 billion

Enterprise value Sector rank

90.82%
ELAN enterprise value is higher than 90.82% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

5.69
ELAN EV/EBITDA is 5.69

EV/EBITDA Sector rank

78.76%
ELAN EV/EBITDA is higher than 78.76% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.44
ELAN annual current ratio is 2.44

Quick ratio

1.25
ELAN annual quick ratio is 1.25

Leverage

Debt to equity

0.71
ELAN annual debt to equity ratio is 0.71

Interest coverage ratio

3.08
ELAN annual interest coverage ratio is 3.08

Risk & Stability

Piotroski F-Score

7
ELAN piotroski f-score is 7

Altman Z-Score

0.88
ELAN altman z-score is 0.88

Analyst ratings

Recent major analysts updates

Apr 14, 25 Stifel
Buy
Mar 6, 25 Piper Sandler
Neutral
Feb 26, 25 UBS
Buy
Feb 26, 25 Stifel
Buy
Feb 26, 25 Morgan Stanley
Equal-Weight
Feb 26, 25 Barclays
Overweight
Feb 21, 25 Stifel
Buy
Jan 29, 25 Morgan Stanley
Equal-Weight
Jan 7, 25 Stifel
Buy
Dec 9, 24 UBS
Buy

Institutional Ownership

Similar stocks

PBH logo
Prestige Consumer Healthcare (PBH)
ITGR logo
Integer Holdings (ITGR)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
BLCO logo
Bausch Lomb (BLCO)
PCVX logo
Vaxcyte (PCVX)
RDNT logo
RadNet (RDNT)
ALHC logo
Alignment Healthcare (ALHC)
INSP logo
Inspire Medical Systems (INSP)
PTCT logo
PTC Therapeutics (PTCT)
  • What is the ticker symbol for Elanco Animal Health Incorporated?
  • Does Elanco Animal Health Incorporated pay dividends?
  • What sector is Elanco Animal Health Incorporated in?
  • What industry is Elanco Animal Health Incorporated in?
  • What country is Elanco Animal Health Incorporated based in?
  • When did Elanco Animal Health Incorporated go public?
  • Is Elanco Animal Health Incorporated in the S&P 500?
  • Is Elanco Animal Health Incorporated in the NASDAQ 100?
  • Is Elanco Animal Health Incorporated in the Dow Jones?
  • When was Elanco Animal Health Incorporated's last earnings report?
  • When does Elanco Animal Health Incorporated report earnings?
  • Should I buy Elanco Animal Health Incorporated stock now?

What is the ticker symbol for Elanco Animal Health Incorporated?

The ticker symbol for Elanco Animal Health Incorporated is NYSE:ELAN

Does Elanco Animal Health Incorporated pay dividends?

No, Elanco Animal Health Incorporated does not pay dividends

What sector is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated is in the Healthcare sector

What industry is Elanco Animal Health Incorporated in?

Elanco Animal Health Incorporated is in the Drug Manufacturers - Specialty & Generic industry

What country is Elanco Animal Health Incorporated based in?

Elanco Animal Health Incorporated is headquartered in United States

When did Elanco Animal Health Incorporated go public?

Elanco Animal Health Incorporated's initial public offering (IPO) was on September 20, 2018

Is Elanco Animal Health Incorporated in the S&P 500?

No, Elanco Animal Health Incorporated is not included in the S&P 500 index

Is Elanco Animal Health Incorporated in the NASDAQ 100?

No, Elanco Animal Health Incorporated is not included in the NASDAQ 100 index

Is Elanco Animal Health Incorporated in the Dow Jones?

No, Elanco Animal Health Incorporated is not included in the Dow Jones index

When was Elanco Animal Health Incorporated's last earnings report?

Elanco Animal Health Incorporated's most recent earnings report was on Feb 25, 2025

When does Elanco Animal Health Incorporated report earnings?

The next expected earnings date for Elanco Animal Health Incorporated is May 7, 2025

Should I buy Elanco Animal Health Incorporated stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page